Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.

k6654_1

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k6654_1.pdf

https://hiroshima.repo.nii.ac.jp/record/2004896/files/k6654_1.pdf

ファイル	ライセンス
k6654_1.pdf (183.0 kB) sha256 c7af5faff9e5cfc8058e32da90bdd9a90c6ee6f85d2fbd295d1b8ab285e0bb9f

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays